Yellow fever overview
|
Yellow fever Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Treatment |
|
Yellow fever overview On the Web |
|
American Roentgen Ray Society Images of Yellow fever overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2]
Overview
Yellow fever is an acute viral disease.[1] It is an important cause of hemorrhagic illness in many African and South American countries despite existence of an effective vaccine. The yellow refers to the jaundice symptoms that affect some patients.[2] Yellow fever has been a source of several devastating epidemics. French soldiers were attacked by yellow fever during the 1802 Haitian Revolution; more than half of the army perished due to the disease.[3] Outbreaks followed by thousands of deaths occurred periodically in other Western Hemisphere locations until research, which included human volunteers (some of whom died), led to an understanding of the method of transmission to humans (primarily by mosquitos) and development of a vaccine and other preventative efforts in the early 20th century. Despite the costly and sacrificial breakthrough research by Cuban physician Carlos Finlay, American physician Walter Reed, and many others over 100 years ago, unvaccinated populations in many developing nations in Africa and Central and South America continue to be at risk.[4] As of 2001, the World Health Organization (WHO) estimates that yellow fever causes 200,000 illnesses and 30,000 deaths every year in unvaccinated populations.[5]
Historical Perspective
Yellow fever has had an important role in the history of Africa, the Americas, Europe, and the Caribbean. Scientists believe that yellow fever evolved in Africa around 3,000 years ago. [6] In 1937 Max Theiler working at the Rockefeller Foundation developed a vaccine for yellow fever that gives a ten-year or more immunity from the disease and effectively protects people traveling to affected areas, while at the same time being a means to control the disease.
Pathophysiology
Causes
Differentiating Yellow Fever from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Primary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
References
- ↑ Schmaljohn AL, McClain D. (1996). Alphaviruses (Togaviridae) and Flaviviruses (Flaviviridae). In: Baron's Medical Microbiology (Baron S et al, eds.) (4th ed. ed.). Univ of Texas Medical Branch. ISBN 0-9631172-1-1.
- ↑ Anker M, Schaaf D; et al. (2000-01-07). "WHO Report on Global Surveillance of Epidemic-prone Infectious Diseases" (PDF). WHO. p. 11. Retrieved 2007-06-11.
- ↑ Bollet, AJ (2004). Plagues and Poxes: The Impact of Human History on Epidemic Disease. Demos Medical Publishing. pp. pp. 48&ndash, 9. ISBN 188879979X.
- ↑ Tomori O (2002). "Yellow fever in Africa: public health impact and prospects for control in the 21st century". Biomedica. 22 (2): 178–210. PMID 12152484.
- ↑ "Yellow fever fact sheet". WHO—Yellow fever. Retrieved 2006-04-18.
- ↑ "Centers for Disease Control and Prevention (CDC). Yellow Fever: History, Epidemiology and Vaccination Information. (Internet). Atlanta, GA: US Department of Health and Human Services, CDC; 2010".